API Ntawm Ib Lub Chaw Pabcuam Ntawm Zhejiang Tianyu Pharmaceutical Co., Ltd. Tau txais kev pom zoo los ntawm CDE.

Feb 25, 2026

Tso lus

Zhejiang Tianyu Pharmaceutical Co., Ltd. (tom qab no hu ua "Lub Tuam Txhab") ntawm no tshaj tawm tias losartan potassium active tshuaj ingredient (API) ntawm nws lub tuam txhab Zhejiang Jingsheng Pharmaceutical Co., Ltd. (tom qab no hu ua "CDE") ntawm National Medical Products Administration. Cov ntaub ntawv ntsig txog tau tshaj tawm raws li hauv qab no:

1. Cov ntaub ntawv tseem ceeb ntawm Cov Tshuaj

Tshuaj Lub Npe: Losartan PotassiumDosage Form: Active Pharmaceutical Ingredient (API) Registration Classification: Class 4 Chemical DrugAPI Registration Number: YBY64562023Joint Review and Approval Result with Formulation: A

2. Lwm cov ntaub ntawv ntsig txog cov tshuaj

Losartan Potassium yog angiotensin II receptor antagonist. Angiotensin II yog lub luag haujlwm tseem ceeb ntawm renin -angiotensin system, ua lub zog vasoconstrictor thiab ua lub luag haujlwm tseem ceeb hauv cov txheej txheem pathophysiological ntawm ntshav siab.

Xa kev nug
Tiv Tauj PebYog muaj lus nug

Koj tuaj yeem tiv tauj peb hauv xov tooj, email lossis online daim ntawv hauv qab no. Peb tus kws tshaj lij yuav hu koj rov qab sai.

Hu rau tam sim no!